Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, December 16, 2022
Catalent announced that it is to establish a new biologics analytical center of excellence in Durham, within North Carolina’s Research Triangle, to offer comprehensive standalone analytical development and testing for biologic drug modalities, ...
read more
Thursday, December 15, 2022
PHASTAR, a global specialist biometrics contract research organization (CRO), has joined Lean Life Science’s Oncology Development Programme (ODP2).
read more
Monday, December 12, 2022
The U.S. Pharmacopeia (USP) announced the opening of the USP Advanced Manufacturing Technology Lab in Richmond, Virginia as part of its launch of a suite of R&D analytical solutions.
read more
Monday, December 12, 2022
Solon, OH: CMC Pharmaceuticals has been awarded a Sequential Phase II Small Business Innovation Research (“SBIR”) grant from the U.S. Defense Department’s (“DoD”) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear ...
read more
Friday, December 09, 2022
Labcorp has begun operations at a new, larger anatomic pathology and histology (APH) laboratory in Los Angeles, expanding the company’s global central laboratory capabilities.
read more
Friday, December 09, 2022
Polyplus has announced the completed acquisition of Xpress Biologics, a Belgian contract development and manufacturing organization (CDMO) specialized in the production of plasmid DNA and protein using microbial expression systems.
read more
Friday, December 09, 2022
Emmes announced the creation of a dedicated center to enhance Emmes’ legacy and depth in cell and gene therapy research.
read more
Wednesday, December 07, 2022
Earlier this year, the company kicked off a program with MassBioEd and Worcester Polytechnic Institute (WPI) to train people re-joining the workforce for stable, attractive biotech manufacturing opportunities.
read more
Wednesday, December 07, 2022
Alliance Pharma has opened its new 20,000-square-foot (1,858-square-meter) bioanalytical laboratory, Alliance Pharma Pty, Ltd., in Brisbane, Australia.
read more
Wednesday, December 07, 2022
Vantage Nutrition, an ACG Group company, announced on 5th December 2022 that it has acquired Philadelphia-based ‘AquaCap’ – an asset of Nestlé Health Science.
read more
Tuesday, December 06, 2022
Fraunhofer IZI, one of Europe’s leading manufacturers of cell and gene therapies for clinical trials, intends to digitalize its manufacturing operations with MODA-ES®, the Manufacturing Execution System from Lonza. Fraunhofer IZI will use Lonza’s ...
read more
Tuesday, December 06, 2022
JRS PHARMA announced the construction of a new manufacturing facility in Cedar Rapids, Iowa. Starting in the fall of 2022, with operations commencing in early 2024, the expansion will be a two-story pre-cast building that will manufacture ...
read more
Tuesday, December 06, 2022
CordenPharma, a full-service Contract Development Manufacturing Organization (CDMO) of innovative Active Pharmaceutical Ingredients (APIs), Lipid Excipients, and Drug Products, is proud to announce that as of 1 December 2022, it has joined the ...
read more
Monday, December 05, 2022
PHASTAR has announced the launch of a pro-bono scheme to give charities access to its volunteer statisticians, data scientists, data managers and programmers at no cost.
read more
Monday, December 05, 2022
Worldwide Clinical Trials has announced the appointment of Pete Duprat as Senior Vice President, Commercial, Early Phase. Duprat will lead business development and commercial activities for the CRO’s Early Phase business unit, consisting of its ...
read more